MedPath

An ayurvedic treatment for Ear Discharge

Phase 2/3
Not yet recruiting
Conditions
Chronic tubotympanic suppurative otitis media. Ayurveda Condition: KARNA-SRAVAH,
Registration Number
CTRI/2023/06/054025
Lead Sponsor
Banaras Hindu University
Brief Summary

The patient diagnosed with Chronic suppurative otitis media fulfilling inclusion and exclusion criteria attending OPD Shalakya tantra and ENT OPD, S.S.Hospital ,IMS, BHU will be assigned into study group and trial group stratified block randomised 6 patient in 1 block with strata of discharge mild, moderate and severe.Each group comprises 100 patients. Study group will receive Sarivadi vati (500mg) 2 tablet bd,after food upto 1 month and dry mopping and Karnadhoopana yoga 5-10 gm for 7 days and control group will receive aural toileting with vinegar (1ml) and normal saline(1ml) for 5 days , local antibiotic ciprofloxacin 2 drops bd  for 5 days. The study will be interventional, comparative RCT. The patients will be assessed based on subjective and objective parameters and follow up for consecutive 2 months in an interval of one month. Subjective parameters will be assessed according to scores -Otorrhea/Ear discharge -quality/quantity, Hearing loss,Tinnitus, Just before commencing treatment, after treatment and during follow up. Objective parameters include Perforation of Tympanic membrane, Pure Tone Audiometry and culture sensitivity test, assessed on before treatment and after treatment. The data collected will be analysed statistically by using appropriate test.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
200
Inclusion Criteria

Patients Suffering from Safe or Tubo-Tympanic Chronic Suppurative Otitis Media without complications Chronicity of the CSOM more than 3 months Patients ready to sign informed consent form.

Exclusion Criteria

Patients Suffering from Unsafe or Attico-antral Chronic Suppurative Otitis Media Chronicity of CSOM less than 3 months CSOM with systemic complications CSOM with serosanguinous discharge CSOM with Sensori-nueral and mixed hearing loss.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Discharge quality and quantityDay 0,Day7, Day15,Day30, Day45, Day 60
Secondary Outcome Measures
NameTimeMethod
Changes in Perforation of TM,Culture and Sensitivity and

Trial Locations

Locations (1)

Sir Sunderlal Hospital

🇮🇳

Varanasi, UTTAR PRADESH, India

Sir Sunderlal Hospital
🇮🇳Varanasi, UTTAR PRADESH, India
Akshata Nara
Principal investigator
08722196150
dr.akshatanara3389@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.